Yes — any company in Cyprus that manufactures, processes, exports, or labels FDA-regulated products for the United States is treated as a foreign facility and must complete U.S. FDA requirements before its goods can enter the U.S. market. Depending on the product, that means foreign facility registration, a U.S. Agent, product listing, and compliant labeling across food, dietary supplements, cosmetics, drugs, and medical devices. This is separate from any approval by Cyprus's own regulator, the Pharmaceutical Services, and clearing one does not clear the other.
FDA Registration Assistance provides U.S. FDA registration and regulatory consulting for companies across Cyprus that export pharmaceuticals, halloumi, wine, food, dietary supplements, cosmetics, pharmaceuticals, and medical devices to the United States. As a U.S.-based firm, we help Cypriot manufacturers, processors, and trading companies register foreign facilities, appoint a U.S. Agent, coordinate FSVP, review labeling, and complete drug, device, and cosmetic requirements before products reach the U.S. market.
Cyprus's exporters center on the ports of Limassol and Larnaca, the capital Nicosia, and the island's pharmaceutical, halloumi, and wine producers. Wherever a Cypriot company is based, FDA requirements apply the same way when its products are sold into the United States, and we support businesses nationwide from our U.S. office.
FDA requirements may apply to foods, fresh produce, dietary supplements, cosmetics, OTC and prescription drugs, and medical devices, depending on intended use, labeling, ingredients, claims, manufacturing, and how products are exported and imported into the United States.
FDA Registration Assistance is based in Miami, Florida and supports Cyprus exporters remotely with foreign facility registration, U.S. Agent service, FSVP coordination, labeling, drug and device listing, and import compliance, with particular depth in pharmaceutical, halloumi, and wine exports.
One of the most common points of confusion for Cypriot exporters is the relationship between the country's own regulator and the U.S. Food and Drug Administration. Cyprus regulates medicines through the Pharmaceutical Services and the Drugs Council of the Ministry of Health, and medical devices through the Competent Medical Equipment Authority, while food safety follows the EU framework under national and EU law. As an EU member since 2004, Cyprus applies EU rules and CE marking, but these are separate from the U.S. FDA and do not transfer. The U.S. FDA governs products entering the United States.
These are two different systems, and clearing one does not clear the other. A medicine, device, food, supplement, or cosmetic that is fully compliant in Cyprus still needs its own U.S. FDA registration, listing, labeling, and, where relevant, U.S. Agent representation before it can be exported to the United States. In the same way, completing FDA requirements does not replace any Cypriot obligation. You can review the FDA's own overview of importing and exporting for context. Our role is to handle the U.S. FDA side so that a company already meeting its home requirements can add U.S. market access cleanly.
Cyprus exports across several FDA-regulated categories, and each follows a different pathway. This overview shows how the main requirements map to the sectors Cypriot companies most often ship to the United States.
| Export Sector | Primary FDA Pathway | Key Point for Cyprus Exporters |
|---|---|---|
| Food & Agricultural Products | Foreign food facility registration, U.S. Agent, Prior Notice, FSVP | Most processed and packaged foods need a registered facility and importer verification before entry. |
| Pharma, Halloumi & Wine | MoCRA for cosmetic pharmaceuticals; TTB for wine; food facility registration, importer FSVP | Cypriot pharma (e.g. Remedica generics) registers with FDA; halloumi is FDA food; wine also involves U.S. TTB. |
| Dietary Supplements | Food facility registration under 21 CFR Part 111, label review | Supplements are regulated as foods, and Supplement Facts and claims must meet U.S. rules. |
| Cosmetics & Personal Care | MoCRA facility registration, product listing, Responsible Person | Modern cosmetic rules require facility registration and a named U.S. Responsible Person. |
| Pharmaceuticals | Drug establishment registration, listing, NDC, U.S. Agent | Foreign drug makers register the establishment and list products, separate from the Pharmaceutical Services approval. |
| Medical Devices | Establishment registration, device listing, classification review | Device requirements depend on classification and the company's role in the U.S. supply chain. |
We publish dedicated FDA service area pages for Cyprus's commercial and manufacturing centers. Explore the city guides below for local detail, or contact us directly if your city is not yet listed — we support exporters across the whole country.
Cyprus's main ports and commercial centers — pharmaceutical, halloumi, wine, food, and consumer-product exporters and the island's primary maritime gateways to the U.S.
The capital of Cyprus and a business and pharmaceutical center — pharmaceutical, food, supplement, cosmetic, and device exporters and brand owners.
We review your products, facilities, and target U.S. market to determine which FDA categories and registrations apply across food, supplement, cosmetic, drug, and device lines.
We identify the required registrations and listings, obtain a DUNS number where needed, and put U.S. Agent representation in place as the FDA's required U.S. contact.
We prepare and submit the registrations and listings, review labels and claims against U.S. rules, and coordinate FSVP and Prior Notice with your U.S. importer.
We manage renewals, keep registrations current, and support FDA communications, so your Cypriot company stays compliant as it grows in the U.S. market.
Whether you export pharmaceuticals, halloumi, wine, food, supplements, or cosmetics, FDA Registration Assistance can map your pathway and handle the U.S. FDA side end to end. Contact our specialists to get started.
Most do. Any Cypriot business that manufactures, processes, packs, holds, labels, or exports FDA-regulated food, dietary supplements, cosmetics, drugs, or medical devices to the United States is treated as a foreign facility or foreign establishment and must meet the applicable FDA registration, listing, and U.S. Agent requirements before products enter the U.S. market.
No. The Cypriot Drug Agency, or the Pharmaceutical Services, is Cyprus's own regulator, and its approval governs the domestic market. U.S. FDA registration is a separate, U.S. requirement that applies when products are exported to the United States. A product cleared by the Cyprus Pharmaceutical Services still needs its own FDA compliance to enter the U.S., and clearing FDA does not replace any Cypriot requirement.
No. The FDA is a U.S. agency and does not register or approve companies through a local office in Cyprus. Foreign facilities interact with the FDA through registration systems and a U.S. Agent based in the United States, which is the point of contact the FDA requires for foreign establishments.
Cypriot exporters commonly deal with food and agricultural products, fresh produce and horticulture, packaged and processed foods, dietary supplements and nutraceuticals, cosmetics and personal care products, and, in some cases, pharmaceuticals and medical devices. Each category has its own FDA pathway, and the right one depends on the product, its intended use, and its labeling.
Yes, in most cases. Any foreign facility that registers with the FDA must appoint a U.S. Agent located in the United States to act as the FDA's contact for communications and, where relevant, inspections. FDA Registration Assistance can serve as the U.S. Agent for eligible Cypriot food, drug, device, and other regulated establishments.
No. For most foods, supplements, and cosmetics, registration and listing are compliance steps, not an approval or endorsement. The FDA does not pre-approve these products, and it is misleading to describe registration as FDA approval. Drugs and certain devices involve additional review pathways that are separate from basic establishment registration.
Not always. Registration is generally facility and product-category specific, so a company that operates more than one facility, or that ships across food, drug, device, or cosmetic categories, may need several registrations and listings. We map which registrations apply across a Cypriot company's sites and product lines.
Many foreign facility registrations can be completed within a few business days once the facility details, product information, DUNS number, and U.S. Agent are in place. Drug, device, and cosmetic pathways can take longer because of listing, classification, and labeling steps, so timelines depend on the product category.
We support businesses across Cyprus, working remotely from our U.S. base. We have dedicated service area pages for Limassol and Larnaca, the main ports, and Nicosia, the capital. These city pages are linked from this country page.
Halloumi is Cyprus's signature cheese and a leading food export, and it is FDA-regulated as food, so exporters register their facility, file Prior Notice, and meet FDA labeling requirements, with the U.S. importer handling FSVP; as a dairy product it can also face additional FDA import checks. Its EU PDO name protection does not change these U.S. requirements. Wine and other alcoholic beverages involve both the FDA and the U.S. Alcohol and Tobacco Tax and Trade Bureau (TTB), which handles permits and label approval for alcohol. Potatoes, citrus, and other foods follow the food-facility pathway with Prior Notice and FDA labeling. Getting the product classification and registration right is what keeps shipments moving through U.S. entry, and we map which apply to a specific Cypriot exporter's products.
The Foreign Supplier Verification Program is the U.S. importer's responsibility, but it directly affects Cypriot suppliers because the importer must verify the foreign supplier meets U.S. food safety standards. We coordinate FSVP between Cypriot exporters and their U.S. importers so the verification records are in place.
The simplest first step is a short review of your products, facilities, and target U.S. market. From there we identify which FDA registrations, listings, U.S. Agent service, and labeling steps apply, and we handle the filings. You can contact FDA Registration Assistance by form, email, or phone to begin.
No. There is no arrangement that lets a Cypriot company skip U.S. FDA registration. Trade preferences and market-access programs can affect tariffs and customs treatment, but they do not change FDA's product safety, registration, listing, or labeling requirements, which apply based on the product and its use in the United States.
FDA's fee structure is based on the product category and activity, not the exporter's country. Some programs, such as certain drug and device user fees, carry government fees, while basic food facility registration does not have an FDA registration fee. We outline any applicable government fees and our service fees up front for each Cypriot pathway.
A company can attempt registration itself, but foreign facilities must appoint a U.S. Agent, obtain a DUNS number, and navigate category-specific listing and labeling rules, which is where errors commonly cause border problems. Using an experienced firm reduces the risk of rejected filings, misclassification, and shipments held at entry.
A DUNS number is a unique business identifier that the FDA uses to verify a facility's identity for food facility registration. Foreign facilities in Cyprus generally need a valid DUNS number that matches the facility's legal name and address before registration can be completed, and we help obtain or correct it where needed.
It depends on the category. Food facility registrations renew every two years during the biennial renewal period, while drug establishment registrations renew annually, and device establishment registrations are also renewed annually with fees. We track renewal windows so a Cypriot company's registrations do not lapse.
The FDA can inspect foreign facilities, and it also relies on import screening, records, and importer verification. Whether or not an inspection happens, a Cypriot facility is expected to meet the applicable U.S. standards, keep records, and respond through its U.S. Agent, so readiness matters regardless of inspection frequency.
The FDA can detain or refuse the shipment at the U.S. port, which usually means storage costs, delays, and possible return or destruction of the goods. Getting registration, labeling, product coding, Prior Notice, and importer verification right before the goods ship is the way to avoid these outcomes.
Yes. We review labels against U.S. requirements, including required statements, Nutrition Facts or Supplement Facts formatting, ingredient and allergen declarations, claims, net quantity, and the responsible firm's U.S. contact details, so products are labeled correctly before printing and export.
Under the modern cosmetic rules, many cosmetic facilities need to register and list products, and a U.S.-based Responsible Person must be identified. Cypriot cosmetic and personal care brands should confirm facility registration, product listing, labeling, and safety substantiation before entering the U.S. market.
The FDA regulates dietary supplements as a category of food, not as drugs, so supplement makers generally need food facility registration and must follow supplement labeling and good manufacturing practice rules. Claims are important, because a supplement that makes disease claims can be treated as an unapproved drug.
Yes. We provide ongoing U.S. Agent representation for eligible Cypriot food, drug, device, and other regulated facilities, serving as the FDA's required U.S. point of contact for communications and inspection-related matters for as long as the registration is active.
Registrations must be kept current and renewed on schedule, and a lapse can require re-registration before shipping resumes. If a Cypriot company pauses exports, it is usually better to keep the registration active and renewed than to let it expire and rebuild it later, and we can advise on the best approach.
We are a U.S.-based firm focused on foreign facility and foreign exporter FDA compliance, so we understand both the FDA's requirements and the practical realities Cypriot exporters face. We map the pathway across food, supplement, cosmetic, drug, and device categories, handle the filings, serve as U.S. Agent, and support renewals and FDA communications end to end.